ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

NYXH Nyxoah SA

9.90
-0.445 (-4.30%)
Last Updated: 14:16:18
Delayed by 15 minutes

Period:

Draw Mode:

Volume 14,123
Bid Price 9.61
Ask Price 9.95
News -
Day High 10.54

Low
4.00

52 Week Range

High
20.00

Day Low 9.43
Company Name Stock Ticker Symbol Market Type
Nyxoah SA NYXH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.445 -4.30% 9.90 14:16:18
Open Price Low Price High Price Close Price Prev Close
10.21 9.43 10.54 10.345
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
318 14,123 $ 9.94 $ 140,314 - 4.00 - 20.00
Last Trade Time Type Quantity Stock Price Currency
14:48:20 1 $ 9.90 USD

Nyxoah SA Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
283.73M 28.66M - 4.35M -43.21M -1.51 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Nyxoah News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NYXH Message Board. Create One! See More Posts on NYXH Message Board See More Message Board Posts

Historical NYXH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week10.2911.539.4310.6615,812-0.39-3.79%
1 Month11.6113.508.28510.4630,058-1.71-14.73%
3 Months10.4020.008.28513.9847,222-0.50-4.81%
6 Months6.1420.004.0010.6541,2973.7661.24%
1 Year8.3920.004.0010.2123,9291.5118.00%
3 Years30.0237.004.0012.0516,773-20.12-67.02%
5 Years30.0237.004.0012.0516,773-20.12-67.02%

Nyxoah Description

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Your Recent History

Delayed Upgrade Clock